Modern begins with the study of COVID-19 vaccine in children
March 16 (Reuters) – Moderna Inc. began dosing patients in a mid-to-late-stage study of its COVID-19 vaccine, mRNA-1273, in children aged six months to less than 12 years, the company said Tu…
